ASX down 0.3%: CSL shares fall

Market Reports

by Peter Milios


Despite a record rally in US markets on Friday, the sharemarket experienced a decline, with the S&P/ASX 200 slipping by 0.27 per cent at 7,623.90 at 11:30am. This decline is primarily attributed to healthcare giant CSL, dropping 5.2 per cent due to abandoning plans for a drug seeking regulatory approval following weak trial results. However, consumer discretionary stocks, notably JB Hi-Fi, have shown resilience, with JB Hi-Fi's shares rising by 1.6 per cent due to better-than-expected sales and revenue in FY24's first half, highlighting a positive trend in the retail sector. Despite the divergence from the S&P 500's upward trajectory, driven by technology stocks' performance, Wall Street remains buoyant, leveraging a robust late-cycle jobs market and optimism in Silicon Valley for AI-driven growth and expanded profit margins.

The SPI futures are pointing to a fall of 34 points.

Best and worst performers

The best-performing sector is Information Technology, up 1.25 per cent. The worst-performing sector is Health Care, down 3.05 per cent.

The best-performing large cap is JB Hi-Fi (ASX:JBH), trading 5.89 per cent higher at $59.88. It is followed by shares in Harvey Norman Holdings (ASX:HVN) and Altium (ASX:ALU).

The worst-performing large cap is CSL (ASX:CSL), trading 4.58 per cent lower at $291.04. It is followed by shares in Fisher & Paykel Healthcare Corporation (ASX:FPH) and IGO (ASX:IGO).

Commodities and the dollar

Gold is trading at US$2039.40 an ounce.

One Australian dollar is buying 65.29 US cents

Peter Milios

Peter Milios is a recent graduate from the University of Technology - majoring in Finance and Accounting. Peter is currently working under equity research analyst Di Brookman for Corporate Connect Research.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?